Recent Advances in Magnetic Resonance Neurospectroscopy

Yael Rosen, Robert E. Lenkinski

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Over the past two decades, proton magnetic resonance spectroscopy (proton MRS) of the brain has made the transition from research tool to a clinically useful modality. In this review, we first describe the localization methods currently used in MRS studies of the brain and discuss the technical and practical factors that determine the applicability of the methods to particular clinical studies. We also describe each of the resonances detected by localized solvent-suppressed proton MRS of the brain and discuss the metabolic and biochemical information that can be derived from an analysis of their concentrations. We discuss spectral quantitation and summarize the reproducibility of both single-voxel and multivoxel methods at 1.5 and 3-4 T. We have selected three clinical neurologic applications in which there has been a consensus as to the diagnostic value of MRS and summarize the information relevant to clinical applications. Finally, we speculate about some of the potential technical developments, either in progress or in the future, that may lead to improvements in the performance of proton MRS.

Original languageEnglish (US)
Pages (from-to)330-345
Number of pages16
JournalNeurotherapeutics
Volume4
Issue number3
DOIs
StatePublished - Jul 2007

Fingerprint

Magnetic Resonance Spectroscopy
Brain
Nervous System
Research
Proton Magnetic Resonance Spectroscopy
Clinical Studies

Keywords

  • Alzheimer's disease
  • brain tumors
  • epilepsy
  • Metabolism
  • MR spectroscopy
  • reproducibility

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Clinical Neurology
  • Pharmacology

Cite this

Recent Advances in Magnetic Resonance Neurospectroscopy. / Rosen, Yael; Lenkinski, Robert E.

In: Neurotherapeutics, Vol. 4, No. 3, 07.2007, p. 330-345.

Research output: Contribution to journalArticle

Rosen, Yael ; Lenkinski, Robert E. / Recent Advances in Magnetic Resonance Neurospectroscopy. In: Neurotherapeutics. 2007 ; Vol. 4, No. 3. pp. 330-345.
@article{87337480c5ca4dd3babe22b46313b730,
title = "Recent Advances in Magnetic Resonance Neurospectroscopy",
abstract = "Over the past two decades, proton magnetic resonance spectroscopy (proton MRS) of the brain has made the transition from research tool to a clinically useful modality. In this review, we first describe the localization methods currently used in MRS studies of the brain and discuss the technical and practical factors that determine the applicability of the methods to particular clinical studies. We also describe each of the resonances detected by localized solvent-suppressed proton MRS of the brain and discuss the metabolic and biochemical information that can be derived from an analysis of their concentrations. We discuss spectral quantitation and summarize the reproducibility of both single-voxel and multivoxel methods at 1.5 and 3-4 T. We have selected three clinical neurologic applications in which there has been a consensus as to the diagnostic value of MRS and summarize the information relevant to clinical applications. Finally, we speculate about some of the potential technical developments, either in progress or in the future, that may lead to improvements in the performance of proton MRS.",
keywords = "Alzheimer's disease, brain tumors, epilepsy, Metabolism, MR spectroscopy, reproducibility",
author = "Yael Rosen and Lenkinski, {Robert E.}",
year = "2007",
month = "7",
doi = "10.1016/j.nurt.2007.04.009",
language = "English (US)",
volume = "4",
pages = "330--345",
journal = "Neurotherapeutics",
issn = "1933-7213",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Recent Advances in Magnetic Resonance Neurospectroscopy

AU - Rosen, Yael

AU - Lenkinski, Robert E.

PY - 2007/7

Y1 - 2007/7

N2 - Over the past two decades, proton magnetic resonance spectroscopy (proton MRS) of the brain has made the transition from research tool to a clinically useful modality. In this review, we first describe the localization methods currently used in MRS studies of the brain and discuss the technical and practical factors that determine the applicability of the methods to particular clinical studies. We also describe each of the resonances detected by localized solvent-suppressed proton MRS of the brain and discuss the metabolic and biochemical information that can be derived from an analysis of their concentrations. We discuss spectral quantitation and summarize the reproducibility of both single-voxel and multivoxel methods at 1.5 and 3-4 T. We have selected three clinical neurologic applications in which there has been a consensus as to the diagnostic value of MRS and summarize the information relevant to clinical applications. Finally, we speculate about some of the potential technical developments, either in progress or in the future, that may lead to improvements in the performance of proton MRS.

AB - Over the past two decades, proton magnetic resonance spectroscopy (proton MRS) of the brain has made the transition from research tool to a clinically useful modality. In this review, we first describe the localization methods currently used in MRS studies of the brain and discuss the technical and practical factors that determine the applicability of the methods to particular clinical studies. We also describe each of the resonances detected by localized solvent-suppressed proton MRS of the brain and discuss the metabolic and biochemical information that can be derived from an analysis of their concentrations. We discuss spectral quantitation and summarize the reproducibility of both single-voxel and multivoxel methods at 1.5 and 3-4 T. We have selected three clinical neurologic applications in which there has been a consensus as to the diagnostic value of MRS and summarize the information relevant to clinical applications. Finally, we speculate about some of the potential technical developments, either in progress or in the future, that may lead to improvements in the performance of proton MRS.

KW - Alzheimer's disease

KW - brain tumors

KW - epilepsy

KW - Metabolism

KW - MR spectroscopy

KW - reproducibility

UR - http://www.scopus.com/inward/record.url?scp=34250718053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250718053&partnerID=8YFLogxK

U2 - 10.1016/j.nurt.2007.04.009

DO - 10.1016/j.nurt.2007.04.009

M3 - Article

C2 - 17599700

AN - SCOPUS:34250718053

VL - 4

SP - 330

EP - 345

JO - Neurotherapeutics

JF - Neurotherapeutics

SN - 1933-7213

IS - 3

ER -